Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors

[Display omitted] Aberrant Class I PI3K signaling is a key factor contributing to many immunological disorders and cancers. We have identified 4-amino pyrrolotriazine as a novel chemotype that selectively inhibits PI3Kδ signaling despite not binding to the specificity pocket of PI3Kδ isoform. Struct...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2016-09, Vol.26 (17), p.4256-4260
Hauptverfasser: Bhide, Rajeev S., Neels, James, Qin, Lan-Ying, Ruan, Zheming, Stachura, Sylwia, Weigelt, Carolyn, Sack, John S., Stefanski, Kevin, Gu, Xiaomei, Xie, Jenny H., Goldstine, Christine B., Skala, Stacey, Pedicord, Donna L., Ruepp, Stefan, Dhar, T.G. Murali, Carter, Percy H., Salter-Cid, Luisa M., Poss, Michael A., Davies, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] Aberrant Class I PI3K signaling is a key factor contributing to many immunological disorders and cancers. We have identified 4-amino pyrrolotriazine as a novel chemotype that selectively inhibits PI3Kδ signaling despite not binding to the specificity pocket of PI3Kδ isoform. Structure activity relationship (SAR) led to the identification of compound 30 that demonstrated efficacy in mouse Keyhole Limpet Hemocyanin (KLH) and collagen induced arthritis (CIA) models.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2016.07.047